Literature DB >> 1468601

The 5 alpha-reductase in the brain: molecular aspects and relation to brain function.

F Celotti1, R C Melcangi, L Martini.   

Abstract

All the classes of hormonal steroids physiologically produced in the body (androgens, estrogens, progestagens, and corticosteroids) are able to exert important effects on the brain, but the mechanisms of their actions are not always well understood. Steroids may interact with intracellular receptors to activate the genome, but some of their effects are probably extragenomic and involve interactions with cellular membranes. Moreover, not all the steroids act always in their native molecular form; a large group of them must actually be transformed into "active" metabolites. This may occur at the level of their respective target structures. For example, androgens are metabolized in the brain into estrogens and into 5 alpha-reduced androgens, like 5 alpha-androstan-17 beta-ol-3-one (dihydrotestosterone; DHT) and 5 alpha-androstan-3 alpha, 17 beta-diol (3 alpha-diol). Progesterone, and possibly corticosteroids, may also be transformed into their corresponding 5 alpha-reduced metabolites. Also the cellular target (neurons and/or glial cells) of the hormonal steroids in the brain is not always clear. This review analyzes in detail one of the two major enzymatic systems that transform steroids in the brain, namely the 5 alpha-reductase-3 alpha-(3 beta)-hydroxysteroid dehydrogenase pathway. An active 5 alpha-reductase-3 alpha-hydroxysteroid dehydrogenase system is widely distributed in practically all CNS structures in all phases of development. In the brain, this enzymatic system is not regulated by castration or sex steroid administration; furthermore, neural inputs seem to be ineffective at the hypothalamic level. A recent interesting finding is the presence of high concentrations of the 5 alpha-reductase in the white matter. This probably is due to the fact that the white matter is particularly rich in myelin membranes, with which the enzymatic activity appears to be associated. An active 5 alpha-reductase activity has also been shown to be present in peripheral myelinated nerves. The localization in myelin membranes may suggest a possible involvement of 5 alpha-reduced metabolites of the different steroids in the process of myelination. The presence of the 5 alpha-reductase was analyzed in neurons, astrocytes, and oligodendrocytes isolated from the brains of male rats, as well as in neurons and glial cells grown in culture. Neurons appear to be more active than glial cells in converting testosterone into DHT. Only neurons possess aromatase activity.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1468601

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN: 0091-3022            Impact factor:   8.606


  43 in total

Review 1.  Neurogenic pain and steroid synthesis in the spinal cord.

Authors:  Christine Patte-Mensah; Cherkaouia Kibaly; Domitille Boudard; Véronique Schaeffer; Aurélie Béglé; Simona Saredi; Laurence Meyer; Ayikoe G Mensah-Nyagan
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  Expression in Escherichia Coli, Purification, and Functional Reconstitution of Human Steroid 5α-Reductases.

Authors:  Hwei-Ming Peng; Juan Valentín-Goyco; Sang-Choul Im; Bing Han; Jiayan Liu; Jie Qiao; Richard J Auchus
Journal:  Endocrinology       Date:  2020-08-01       Impact factor: 4.736

3.  Effect of age on synthesis of the GABAergic steroids 5-alpha-pregnane-3,20-dione and 5-alpha-pregnane-3-alpha-ol-20-one in rat cortex in vitro.

Authors:  H J Stuerenburg; U Fries; F Iglauer; K Kunze
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

4.  Advances in the translational neuroscience of neurosteroids.

Authors:  C Neill Epperson; Harriet deWit; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2006-05-03       Impact factor: 4.530

5.  Female mice with deletion of Type One 5α-reductase have reduced reproductive responding during proestrus and after hormone-priming.

Authors:  Carolyn J Koonce; Cheryl A Frye
Journal:  Pharmacol Biochem Behav       Date:  2014-03-18       Impact factor: 3.533

Review 6.  Gonadal steroids and neuronal function.

Authors:  R Alonso; I López-Coviella
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

7.  Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study.

Authors:  Laura E Dichtel; Linda L Carpenter; Maren Nyer; David Mischoulon; Allison Kimball; Thilo Deckersbach; Darin D Dougherty; David A Schoenfeld; Lauren Fisher; Cristina Cusin; Christina Dording; Nhi-Ha Trinh; Paola Pedrelli; Albert Yeung; Amy Farabaugh; George I Papakostas; Trina Chang; Benjamin G Shapero; Justin Chen; Paolo Cassano; Emily M Hahn; Elizabeth M Rao; Roscoe O Brady; Ravinder J Singh; Audrey R Tyrka; Lawrence H Price; Maurizio Fava; Karen K Miller
Journal:  Am J Psychiatry       Date:  2020-07-14       Impact factor: 18.112

8.  Effects of dihydrotestosterone on brain mRNA levels of steroid 5alpha-reductase isozymes in early postnatal life of rat.

Authors:  Pilar Sánchez; Jesús M Torres; Esperanza Ortega
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

Review 9.  Testosterone and progesterone metabolism in the central nervous system: cellular localization and mechanism of control of the enzymes involved.

Authors:  L Martini; F Celotti; R C Melcangi
Journal:  Cell Mol Neurobiol       Date:  1996-06       Impact factor: 5.046

10.  Testosterone conversion blockade increases breathing stability in healthy men during NREM sleep.

Authors:  Susmita Chowdhuri; Amy Bascom; David Mohan; Michael P Diamond; M Safwan Badr
Journal:  Sleep       Date:  2013-12-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.